Posts by: Patricia Inacio PhD

News

Layla, a 1-year-old girl with leukemia, received gene-edited immune cells from a healthy donor and is now reported to be effectively in remission. Layla, who failed to respond to all previous treatments, ... Read more

November 9, 2015November 9, 2015

JEDI Technology Throws Light onto Immune Systems in Motion

News

In a new study entitled “GFP-specific CD8 T cells enable targeted cell depletion and visualization of T-cell interactions,” a team of researchers developed a new technology, called JEDI T-cells, that ... Read more

November 3, 2015November 3, 2015

Epigenetic Drugs May Enhance Cancer Immunotherapy Efficacy

News

In a new study entitled “Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy” researchers at the University of Michigan Comprehensive Cancer Center discovered a new mechanism by which ... Read more

November 2, 2015November 2, 2015

Pancreatic Cancer Immunotherapy Increases Survival in Mouse Models

News

In a recent study entitled “T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma,” scientists discovered that a newly designed immunotherapy – T cells ... Read more

September 29, 2015September 29, 2015

Cancer Immunotherapy Achievements And Future Goals – Professor Peter Johnson’s Opinion

News

Professor Peter Johnson, Cancer Research UK’s Chief Clinician and director of the Southampton Cancer Research UK Centre recently shared his vision on cancer immunotherapy field, i.e., a strategy that fights ... Read more

September 17, 2015September 18, 2015

Epigenetic Drugs Combined with Immunotherapies May Promote Better Clinical Outcomes in Cancer Patients

News

In a new review study entitled “Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy” a team of researchers suggests that epigenetic therapies, when combined with immunotherapy drugs, benefit ... Read more

September 14, 2015September 14, 2015

New Method Allows More Efficient Monoclonal Antibody Production

News

In a recent study entitled “Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells” a team of researchers at the A*STAR Bioprocessing Technology Institute developed a ... Read more

September 9, 2015September 9, 2015

Aspirin Boosts Immunotherapy Effect In Mouse Models of Cancer

News

In a new study entitled “Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity” scientists at The Francis Crick Institute discovered that administrating aspirin (or other COX inhibitors) together with immunotherapies boosts ... Read more

August 27, 2015August 27, 2015

Combined Bavituximab – Anti-PDL1 Therapies Enhance Immune Responses

News

Peregrine Pharmaceuticals, Inc. recently presented the latest results on several studies with bavituximab, their investigational phosphatidylserine (PS)-signaling pathway inhibitor, during the 10th Annual Immunotherapy and Vaccine Summit (ImVacS) in Boston, MA. Bavituximab is a chimeric monoclonal ... Read more

August 4, 2015August 4, 2015

Report Summarizes 2015 Immune Therapies Status

News

Immune therapies have seen a remarkable expansion in the last few years under the principle that enhancing the action of our own immune system is an effective way to combat ... Read more